Stock AXPH ALEXANDRIA CO. FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES
Add to a list
To use this feature you must be a member
Log inSign up

Alexandria Co. For Pharmaceuticals & Chemical Industries Share Price

Equities

AXPH

EGS38341C011

Pharmaceuticals

End-of-day quote Egyptian Exchange
Other stock markets
 03:30:00 27/06/2024 am IST 		5-day change 1st Jan Change
210.7 EGP 0.00% Intraday chart for Alexandria Co. For Pharmaceuticals & Chemical Industries +0.29% +18.20%
2023 Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
2022 Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022 CI

Financials

Sales 2022 121.7Cr 2.54Cr 211.38Cr Sales 2023 148.43Cr 3.09Cr 257.81Cr Capitalization 69Cr 1.44Cr 120.01Cr
Net income 2022 13Cr 26.89L 22Cr Net income 2023 13Cr 26.26L 22Cr EV / Sales 2022 0.32 x
Net cash position 2022 14Cr 30.14L 25Cr Net cash position 2023 7.85Cr 16.36L 14Cr EV / Sales 2023 0.41 x
P/E ratio 2022
4.1 x
P/E ratio 2023
5.47 x
Employees -
Yield 2022 *
-
Yield 2023
9.41%
Free-Float 19.62%
More Fundamentals * Assessed data

Chart Alexandria Co. For Pharmaceuticals & Chemical Industries

Dynamic Chart

Latest news about Alexandria Co. For Pharmaceuticals & Chemical Industries

Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2022 CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2021 CI
VAlexandria Pharmaceuticals Announces Consolidated Earnings Results for the Six Months Ended December 31, 2020 CI
Alexandria Co. for Pharmaceuticals and Chemical Industries Recommends Cash Dividend for Fiscal Year 2019/2020 CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Announces Earnings Results for the Year Ended on 30 June 2020 CI
Alexandria Pharmaceuticals Announces Earnings Results for the Year Ended June 30, 2019 CI
Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2018 CI
Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Reviewed Earnings Results for the Period Ended December 31, 2018 CI
Alexandria Pharmaceuticals Reports Earnings Results for the Three Months Ended September 30, 2018 CI
Alexandria Pharmaceuticals Declares Cash Dividend, Payable on October 28, 2018 CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended June 30, 2018 CI
Alexandria Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2018 CI
Alexandria Pharmaceuticals Reports Earnings Results for the Half Year Ended December 31, 2017 CI
More news

Press releases Alexandria Co. For Pharmaceuticals & Chemical Industries

Alexandria For Pharmaceuticals & Chemical Industries : Pharmaceuticals (AXPH.CA) Reports 6 Months Results PU
More press releases

Quotes and Performance

1 week+0.29%
Current month-3.71%
1 month-3.71%
3 months-9.22%
6 months+18.20%
Current year+18.20%
More quotes

Highs and lows

1 week
209.05
Extreme 209.05
217.99
1 month
209.05
Extreme 209.05
225.00
Current year
178.50
Extreme 178.5
250.00
1 year
120.00
Extreme 120
250.00
3 years
85.00
Extreme 85
250.00
5 years
85.00
Extreme 85
250.00
10 years
42.30
Extreme 42.3
250.00
More quotes

Managers and Directors - Alexandria Co. For Pharmaceuticals & Chemical Industries

Managers TitleAgeSince
Abla Youssef Abdullah CEO
 Chief Executive Officer - -
Mohammed Noman Salamah DFI
 Director of Finance/CFO - -
Ahmed Fuad ADM
 Chief Administrative Officer - -
Members of the board TitleAgeSince
Mustafa Abdel Monem El-Hayawan CHM
 Chairman - -
Sherif Salah Mohammed Tahoun BRD
 Director/Board Member - -
Abla Youssef Abdullah CEO
 Chief Executive Officer - -
More insiders

Quotes

Date Price Change Volume
27/24/27 210.7 0.00% 645
26/24/26 210.7 0.00% 35
25/24/25 210.7 0.00% 406
24/24/24 210.7 0.00% 742

End-of-day quote Egyptian Exchange, June 27, 2024

More quotes

Company Profile

Alexandria Co. for Pharmaceuticals & Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, dermatological, cardiovascular, allergic, epileptic, gastrointestinal diseases, etc. The group also provides veterinary and medical products (adhesive tape, gauze compresses, gloves, traction kits, etc.).
Sector
Pharmaceuticals
More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ALEXANDRIA CO. FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES Stock Alexandria Co. For Pharmaceuticals & Chemical Industries
+18.20% 2.19Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 82TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+44.05% 64TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 31TCr
ABBVIE INC. Stock AbbVie Inc.
+10.68% 30TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 24TCr
NOVARTIS AG Stock Novartis AG
+13.31% 22TCr
AMGEN INC. Stock Amgen Inc.
+8.48% 17TCr
PFIZER, INC. Stock Pfizer, Inc.
-2.81% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AXPH Stock